Richard J Wallace has joined the Bridgehead Board as a Non-Executive Director, following 15 years at GlaxoSmithKline (GSK), where he was most recently Senior Vice President of Global Product Strategy, accountable for Global Health Outcomes, Scientific Communications, Global Commercial Strategy and Business & Commercial Analysis. He also served as a member of its Research and Development Executive, Commercial Operations Committee, Product Management Board and Scientific Advisory Board. During his years at GSK and its heritage companies, Richard held positions from Vice President Commercial (Canadian Pharmaceuticals), Vice President U.S. Business Development, Vice President Sales & Marketing (U.S. Oncology and HIV), Vice President Clinical Development and Product Strategy, and Vice President of Global Commercial Strategy.
His experience prior to joining GSK included eight years with Bristol-Myers Squibb and seven years at Johnson & Johnson in assignments from Marketing, Sales, Manufacturing and General Management.
Richard received BCom and BCom(Hons) degrees from Rhodes University, South Africa and currently serves on the board of directors of ImmunoGen Inc and Clinical Data Inc.
